TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
123
|
116
|
126 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
67
|
33
|
21 |
| EBITDA |
64
|
32
|
21 |
| Total assets |
200
|
197
|
233 |
| Current assets |
200
|
197
|
233 |
| Current liabilities |
2
|
1
|
19 |
| Equity capital |
193
|
190
|
208 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
96.5%
|
96.4%
|
89.3% |
| Turnover per employee |
123
|
116
|
126 |
| Profit as a percentage of turnover |
54.5%
|
28.4%
|
16.7% |
| Return on assets (ROA) |
33.5%
|
16.8%
|
9.0% |
| Current ratio |
10000%
|
19700%
|
1226.3% |
| Return on equity (ROE) |
34.7%
|
17.4%
|
10.1% |
| Change turnover |
7
|
0
|
-58 |
| Change turnover % |
6%
|
0%
|
-31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.